Key result
The Perceval sutureless valve has been used as an alternative treatment for aortic stenosis for over 10 years, with nearly 600 implants performed at the Montreal Heart Institute since 2011.
This article provides an overview of clinical data and a 10-year institutional experience with the Perceval sutureless valve for aortic stenosis.
Answers are grounded in this paper and cite their sources.
May inform sutureless valve selection in aortic stenosis; leaves open need for randomized durability comparisons.
Aortic stenosis has traditionally been addressed with surgical aortic valve replacement (AVR). In recent years, several technologies have emerged as alternative treatment methods for aortic valve disease. Among them, the Perceval (LivaNova, London, UK) is a sutureless valve that has been used in clinical practice for over 10 years. It has been implanted in over 20,000 patients worldwide. With nearly 600 Perceval implants since 2011, the Montreal Heart Institute has developed a worldwide expertise with this technology. In this article, we provide an overview of the clinical data currently available in the literature and discuss the lessons we have learned from our experience with the Perceval prosthesis.
No takes yet. Share an insight, caveat, or question.
Chauvette et al. (2018) conducted a review in Aortic stenosis. Perceval S sutureless prosthesis was evaluated. The Perceval sutureless valve has been used as an alternative treatment for aortic stenosis for over 10 years, with nearly 600 implants performed at the Montreal Heart Institute since 2011.
Synapse has enriched 10 related papers. Consider them for comparative context: